Pancreatic Cancer Research

ResearcherKeio UniversityActive in the last 2 years

Satoko Hori

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-4596-5418; OpenAlex author ID A5084452040. Sources: OpenAlex.

Their work

Papers
2 (first author 0, last author 2)
Trials
0
Grants
0
Labs led
1
Collaborators
5
Papers, trials and grants by year

2021: 1 paper · 2022: none · 2023: none · 2024: none · 2025: 1 paper

Papers 2

  1. Factors Affecting Delayed Recovery from Neutropenia in Patients with Pancreatic Cancer Receiving Gemcitabine plus Nab-Paclitaxel. Last author DOI 10.7150/jca.107359↗
  2. Risk factors for severe neutropenia in pancreatic cancer patients treated with gemcitabine/nab-paclitaxel combination therapy. Last author DOI 10.1371/journal.pone.0254726↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Takashi Yokokawa · 2 shared papers, 2021–2025 · strength 0.34
  2. Masato Ozaka · 2 shared papers, 2021–2025 · strength 0.34
  3. Naoki Sasahira · 2 shared papers, 2021–2025 · strength 0.34
  4. Naoko Yoshida · 1 shared paper, 2025 · strength 0.21
  5. Genta Ito · 1 shared paper, 2021 · strength 0.12

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.